DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

By Maria Cramer and Hurubie Meko “We’ve got to take back 42nd Street,” Curtis Sliwa, the founder of the anti-crime group, said on “Hannity” as the Guardian Angels pushed a man to the ground.

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Medtronic PLC closed $2.15 below its 52-week high ($91.49), which the company reached on September 4th.

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

This year's Marathon Weekend is Friday, Oct. 4 through Sunday ... Runners will line up at the start line for the Medtronic Twin Cities Marathon in downtown Minneapolis at the corner of South ...

From new leadership and expansions, here are five key updates from spine and orthopedic devicemakers since Sept. 11.

Medtronic (NYSE: MDT ... Over the last 12 months, the company has pulled in profits of around $4 billion on revenue of approximately $33 billion, with an operating cash flow of nearly 7 billion.

the ROE for Medtronic is: 8.2% = US$4.0b ÷ US$48b (Based on the trailing twelve months to July 2024). The 'return' is the amount earned after tax over the last twelve months. So, this means that ...

Medical device giant Medtronic (NYSE: MDT) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue ...

That said, Medtronic's operational execution is improving. Revenue increased around 3.6% in fiscal year 2024, although EPS fell about 1.5%. However, the company forecasts a 4% to 5% revenue ...